Suppr超能文献

激活环酪氨酸磷酸化在 c-Kit 自身激活机制中的作用及其在舒尼替尼耐药中的意义。

Function of activation loop tyrosine phosphorylation in the mechanism of c-Kit auto-activation and its implication in sunitinib resistance.

机构信息

Pfizer Research Technology Center, 620 Memorial Drive, Cambridge, MA 02139, USA.

出版信息

J Biochem. 2010 Apr;147(4):601-9. doi: 10.1093/jb/mvq015. Epub 2010 Feb 10.

Abstract

The activation of receptor tyrosine kinases (RTKs) is tightly regulated through a variety of mechanisms. Kinetic studies show that activation of c-Kit RTK occurs through an inter-molecular autophosphorylation. Phosphopeptide mapping of c-Kit reveals that 14-22 phosphates are added to each mol of wild-type (WT) c-Kit during the activation. Phosphorylation sites are found on the JM, kinase insert (KID), c-terminal domains and the activation loop (A-loop), but only the sites on the JM domain contribute to the kinase activation. The A-loop tyrosine (Y(823)) is not phosphorylated until very late in the activation (>90% completion), indicating that the A-loop phosphorylation is not required for c-Kit activation. A sunitinib-resistant mutant D816H that accelerates auto-activation by 184-fold shows no phosphorylation on the A-loop tyrosine after full activation. A loss-of-phosphorylation mutation Y823F remains fully competent in auto-activation. Similar to WT and D816H, the unactivated Y823F mutant binds sunitinib and imatinib with high affinity (K(D) = 5.9 nM). But unlike the WT and D816H where the activated enzymes lose the ability to bind the two drugs, activated Y823F binds the two inhibitors effectively. These observations suggest that the A-loop of activated Y823F remains flexible and can readily adopt unactivated conformations to accommodate DFG-out binders.

摘要

受体酪氨酸激酶 (RTKs) 的激活受到多种机制的严格调控。动力学研究表明,c-Kit RTK 的激活是通过分子间的自身磷酸化来实现的。对 c-Kit 的磷酸肽图谱分析表明,在激活过程中,每个 WT c-Kit 分子会添加 14-22 个磷酸。磷酸化位点位于 JM、激酶插入 (KID)、C 端结构域和激活环 (A 环) 上,但只有 JM 结构域上的位点对激酶的激活有贡献。A 环酪氨酸 (Y(823)) 在激活过程中很晚才被磷酸化(>90%完成),这表明 A 环磷酸化不是 c-Kit 激活所必需的。一个能使自身激活速度加快 184 倍的对舒尼替尼耐药的 D816H 突变体在完全激活后 A 环酪氨酸没有被磷酸化。一个失去磷酸化能力的 Y823F 突变体仍然完全有能力进行自身激活。与 WT 和 D816H 相似,未激活的 Y823F 突变体与舒尼替尼和伊马替尼具有高亲和力(K(D) = 5.9 nM)。但与 WT 和 D816H 不同的是,激活后的酶失去了与这两种药物结合的能力,而激活后的 Y823F 可以有效地结合这两种抑制剂。这些观察结果表明,激活的 Y823F 的 A 环仍然具有灵活性,可以很容易地采用非激活构象来容纳 DFG-out 结合物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验